Matinas Biopharma Holdings, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.75
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.03
|
-0.03
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.03
|
-0.03
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.02
|
-0.03
|
-0.01
|
-50.00%
|
|
2021-12-31
|
-0.03
|
-0.03
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.02
|
-0.03
|
-0.01
|
-50.00%
|
|
2021-06-30
|
-0.03
|
-0.02
|
0.01
|
33.33%
|
|
2021-03-31
|
-0.03
|
-0.03
|
0.00
|
0.00%
|
|
2020-12-31
|
-0.03
|
-0.03
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.09
|
|
2021-12-31
|
-0.11
|
|
2020-12-31
|
-0.12
|
|
2019-12-31
|
-0.13
|
|
2018-12-31
|
-0.15
|
|
2017-12-31
|
-0.37
|
|
2016-12-31
|
-0.21
|
|
2015-12-31
|
-0.18
|
|
2014-12-31
|
-0.25
|